An unidentified man died Sunday, January 17, 2016 at Rennes University Hospital in France following his participation in a flawed experimental drug test. He had been admitted to the hospital and diagnosed as brain dead on Monday, January 11, 2016. He was one of ninety participants who agreed to be test subjects for a new drug proven compatible with chimpanzees.
The participants began the drug trial on Thursday, January 7, 2016. Sunday one man began to feel sick with others following close afterwards. Monday, the first man ( now deceased ) was taken to the hospital, Wednesday and Thursday the remaining four were hospitalized. The drug has been found to be defective and harmful, with three others remaining in the hospital, diagnosed with irreversible neurological damage and a fifth man with neurological problems. The men now have a higher risk of cancer and autoimmune diseases tied to their exposure to the experimental drug. Not all the participants in the trial took the medication, many were given placebos and consequently were unharmed.
Marisol Tourmaline, the French health minister, has terminated the testing of all 90 participants from further use of the drug which originated at the Portuguese Pharmaceutical Firm Bial in north west France. French prosecutors have launched a manslaughter investigation into this unusual case, which spotlighted the practice of testing drugs, proven safe when given to animals, on paid, healthy human volunteers.
The procedure that caused this tragic outcome was the first step in qualifying medication as compatible with human DNA. The initial introduction of the new pill to humans demonstrates how well it is tolerated and exposes any serious negative effects on people. Touraine said the drug was a so-called FAAH inhibitor meant to act on the body’s endocannabinoid system, which deals with pain. The drug was not based on marijuana or cannabis, as some reported.
The men agreeing to become test subjects, for a drug that was compatible with chimpanzees, have lost their life or will never recover, three of the patients may be suffering from irreversible brain damage This all could have been prevented and realistically should not have happened, human’s DNA does not duplicate that of a chimpanzee. Animals are not an alternate test subjects for people nor can they be valid research subjects for treating or curing human diseases or afflictions.
In December 2011, a groundbreaking report by the Institute of Medicine and National Research Council (MNRC) found that most biomedical and behavioral research on chimpanzees are unnecessary and could not identify any area of current biomedical research for which chimpanzee use is essential. It was demonstrated that the use of many diverse alternatives now available or under study are superior and far safer for humans than using chimpanzees or any animal. The MNRC called for the financing and the continued creation of alternative choices that are valid and focus on human DNA.
This situation brings to question why those educated in scientific studies would use any animal for their research. Scientists understand we don’t share the same genetic makeup as chimpanzees. Why do they continue to practice vivisection on animals?
Today we have families left in shock, one planning a funeral and the others trying to cope with their loved ones permanent neurological damage. There is no justification for this tragedy, humans are not chimpanzees. Animals aren’t test subjects to be probed, drugged, mutilated and discarded like trash. Pharmaceutical companies should not expect humans to risk being victims of botched science when alternative scientific tests are more reliable than animal tests.